glycogen storage disease XV
ORPHA: 263297
Overview
Human disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with glycogen storage disease XV, sourced from HPO and Orphanet clinical annotations.
CardiomyopathyVentricular fibrillationVentricular hypertrophyPalpitationsVertigoExertional dyspneaDecreased muscle massEMG: myopathic abnormalitiesUpper limb muscle weaknessShoulder girdle muscle weaknessNeck flexor weaknessVentricular tachycardiaVentricular septal hypertrophyAbdominal wall muscle weaknessFoot dorsiflexor weaknessT-wave inversionArrhythmiaComplete right bundle branch blockST segment elevationDecreased muscle glycogen contentCardiomyocyte hypertrophyIncreased mitochondrial number
Classification & Codes
Orphanet Code
ORPHA:263297glycogen storage disease XV
| Orphanet | ORPHA:263297 |
| Treatments | 0 drug(s) |
| Symptoms on record | 22 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO